PR Newswire
NEW YORK, Jan. 17, 2018
NEW YORK, Jan. 17, 2018 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential wrongdoing at United Therapeutics Corporation ("United Therapeutics" or the "Company") (NASDAQ: UTHR).
The investigation focuses on whether the Company and/or its directors and officers breached their fiduciary duties.
Request more information now by clicking here: www.faruqilaw.com/UTHR. There is no cost or obligation to you.
Take Action
If you currently own United Therapeutics stock and would like to discuss your legal rights, please visit www.faruqilaw.com/UTHR. You can also contact us by calling Nina Varindani, Esq. either via e-mail at nvarindani@faruqilaw.com or by telephone at (877) 247-4292 or (212) 983-9330 or Michael Van Gorder, Esq. at mvangorder@faruqilaw.com.
Faruqi & Faruqi, LLP also encourages anyone with information regarding the Company's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
Nina Varindani, Esq.
Michael Van Gorder, Esq.
FARUQI & FARUQI, LLP
685 Third Avenue, 26th Floor
New York, NY 10017
Telephone: (877) 247-4292 or (212) 983-9330
nvarindani@faruqilaw.com
mvangorder@faruqilaw.com
View original content with multimedia:http://www.prnewswire.com/news-releases/faruqi--faruqi-llp-is-investigating-united-therapeutics-corporation-uthr-on-behalf-of-its-shareholders-300584197.html
SOURCE Faruqi & Faruqi, LLP
Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.